Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$94.10 USD

94.10
1,891,045

-0.36 (-0.38%)

Updated Jul 12, 2024 03:59 PM ET

After-Market: $94.12 +0.02 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Three Reasons to Retain Accuray (ARAY) Stock in Your Portfolio

The continued solid demand for Accuray's (ARAY) products raises optimism about the stock.

Illumina (ILMN) Rides on NGS Portfolio Expansion Amid Macro Woe

In reproductive health, Illumina (ILMN) primarily focuses on driving noninvasive prenatal testing (NIPT) adoption globally.

SenesTech (SNES) Expands in the Netherlands With Q-chem Deal

SenesTech's (SNES) collaboration with Q-chem strategically aligns with the Netherlands' Integrated Pest Control program.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why You Should Retain Penumbra (PEN) Stock for Now

Investors remain optimistic for Penumbra (PEN), backed by the strength of its portfolio.

Thermo Fisher (TMO) Introduces Dionex Inuvion IC system

Thermo Fisher's (TMO) Dionex Inuvion system helps labs operate more effectively by providing simple, adjustable workflows and a small footprint.

Is Cardinal Health (CAH) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

QIAGEN (QGEN) Earns Notable Recognitions in Sustainability

QIAGEN (QGEN) achieves the ACT Label for new eco-friendly QIAwave products and the first My Green Lab Platinum certification.

National Vision (EYE) Hurt by Business Closure, Macro Woe

National Vision's (EYE) impending termination of the long-term partnership with Walmart is likely to significantly impact its business.

Is American Century U.S. Quality Value ETF (VALQ) a Strong ETF Right Now?

Smart Beta ETF report for VALQ

IDEXX (IDXX) Unveils Pet Owner Engagement Software Solution

IDEXX's (IDXX) Vello software is an intuitive solution designed specifically for practice management software that enables practitioners to interact with pet owners before and after visits.

Integer Holdings (ITGR) Q4 Earnings and Sales Beat, Margins Up

Integer Holdings (ITGR) reports fourth-quarter results, with earnings and revenues beating their respective consensus marks.

PacBio (PACB) Q4 Earnings Beat, Adjusted Gross Margin Down

PacBio (PACB) witnesses strong revenue growth in the fourth quarter, partly aided by customers' continued product transition to the Revio system.

AMN Healthcare (AMN) Q4 Earnings and Revenues Beat Estimates

AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall fourth-quarter performance.

ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 (Revised)

ResMed's (RMD) new AirCurve11 series incorporates MyAir and AirView digital health apps to provide maximum comfort and support during therapy.

Shockwave Medical (SWAV) Q4 Earnings Beat, Revenues Rise Y/Y

Shockwave Medical's (SWAV) fourth-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.

Bio-Rad (BIO) Q4 Earnings Beat, Revenues Miss, Margins Down

Bio-Rad (BIO) continues to experience weak demand for Life Science products in China.

Here's Why You Should Retain Insulet (PODD) Stock for Now

The huge success of Omnipod 5 boosts investors' confidence in Insulet (PODD).

West Pharmaceutical (WST) Beats on Q4 Earnings, HVP Drives Sales

West Pharmaceutical's (WST) fourth-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.

Labcorp (LH) Q4 Earnings and Revenues Beat, Margins Fall

Strength in Diagnostics Laboratories and Biopharma Laboratory Services businesses contributes to Labcorp's (LH) Q4 performance.

Here's Why You Should Retain IDEXX (IDXX) Stock for Now

Investors are optimistic about IDEXX (IDXX) growth in CAG business and strong global performance

Avantor (AVTR) Q4 Earnings & Revenues Top Estimates, Margins Down

Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft fourth-quarter performance.

Quest Diagnostics (DGX) Boosts Oncology Portfolio With New Test

Quest Diagnostics (DGX) debuts the MelaNodal Predict test in collaboration with SkylineDx.

Here's Why You Should Retain CVS Health (CVS) Stock for Now

Investors are optimistic about CVS Health (CVS) on its strong segmental performance and impressive restructuring plan.

Bruker (BRKR) Q4 Earnings Surpass Estimates, Margins Down

Strength in BioSpin and CALID groups contributes to Bruker's (BRKR) Q4 revenues.